We are live on ! Find out more
LJPC

La Jolla Pharmaceutical Company
LJPC

Delisted

LJPC was delisted on the 19th of August, 2022.

Back to rankings

62 hedge funds and large institutions have $78.6M invested in La Jolla Pharmaceutical Company in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 31 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more call options, than puts

Call options by funds: $304K | Put options by funds: $268K

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

11% less capital invested

Capital invested by funds: $88.1M → $78.6M (-$9.52M)

18% less funds holding

Funds holding: 76 → 62 (-14)

61% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 23

65% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 31

Holders
62
Holders Change
-14
Holders Change %
-18.42%
% of All Funds
1.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
11
Reduced
31
Closed
23
Calls
$304K
Puts
$268K
Net Calls
+$36K
Net Calls Change
+$216K

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$2.76M
2
Millennium Management
Millennium Management
New York
+$968K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$880K
4
E
Ergoteles
New York
+$353K
5
TEE
Tibra Equities Europe
United Kingdom
+$311K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.77M
2
Wells Fargo
Wells Fargo
California
-$1.56M
3
State Street
State Street
Massachusetts
-$1.29M
4
Norges Bank
Norges Bank
Norway
-$1.1M
5
Charles Schwab
Charles Schwab
California
-$772K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$10K -$5.99K -1,399 -37%
APA
52
American Portfolios Advisors
New York
$6.42K – – –
PAM
53
Panagora Asset Management
Massachusetts
$4K – – –
SIC
54
Salem Investment Counselors
North Carolina
$4K – – –
SWA
55
SOA Wealth Advisors
New York
$4K – – –
Simplex Trading
56
Simplex Trading
Illinois
$2K -$65.7K -15,330 -97%
Fidelity Investments
57
Fidelity Investments
Massachusetts
$2K +$2.14K +500 New
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$1K -$42.2K -9,844 -98%
Group One Trading
59
Group One Trading
Illinois
$1K -$27.2K -6,349 -96%
HI
60
Harbour Investments
Wisconsin
$1K – – –
Nisa Investment Advisors
61
Nisa Investment Advisors
Missouri
$3 – – –
Norges Bank
62
Norges Bank
Norway
– -$1.1M -259,676 Closed
Charles Schwab
63
Charles Schwab
California
– -$772K -181,934 Closed
N
64
Nuveen
North Carolina
– -$620K -146,256 Closed
AllianceBernstein
65
AllianceBernstein
Tennessee
– -$350K -82,600 Closed
PAM
66
Premier Asset Management
Illinois
– -$217K -51,305 Closed
California Public Employees Retirement System
67
California Public Employees Retirement System
California
– -$179K -42,200 Closed
Renaissance Technologies
68
Renaissance Technologies
New York
– -$142K -33,600 Closed
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
– -$116K -27,276 Closed
TI
70
Trexquant Investment
Connecticut
– -$106K -25,006 Closed
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
– -$104K -24,411 Closed
EGM
72
Engineers Gate Manager
New York
– -$70K -16,400 Closed
CSS
73
Cubist Systematic Strategies
Connecticut
– -$69K -16,218 Closed
State Board of Administration of Florida Retirement System
74
State Board of Administration of Florida Retirement System
Florida
– -$63K -14,745 Closed
VF
75
Virtu Financial
New York
– -$50K -11,843 Closed
1 2
3
4

LJPC Hedge Fund Activity: Q2 2021 in Review

62 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q2 2021, worth a combined $78.6M — down 11% from $88.1M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of LJPC and 9 opened new positions — a net loss of 14 holders — while 31 trimmed existing stakes and 11 added.

The largest buyer was Tang Capital Management, adding an estimated $2.76M. The largest seller was BlackRock, cutting an estimated $4.77M.

  • 62 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q2 2021, down from 76 in Q1 2021.
  • Funds reported $78.6M of La Jolla Pharmaceutical Company stock for Q2 2021, down 11% quarter-over-quarter.
  • 9 funds opened new La Jolla Pharmaceutical Company positions in Q2 2021 and 23 closed out, a net change of -14 holders.
  • The largest La Jolla Pharmaceutical Company buyer in Q2 2021 was Tang Capital Management, an estimated $2.76M added.
  • The largest La Jolla Pharmaceutical Company seller in Q2 2021 was BlackRock, an estimated $4.77M sold.

Based on aggregated 13F filings for Q2 2021.